Tempest Therapeutics公布收购CAR T资产计划
Tempest Therapeutics outlines plans for acquired CAR T assets
生物技术与制药领域的最新动态
Tempest Therapeutics outlines plans for acquired CAR T assets
SUDO-550 demonstrates robust efficacy in MS models
Precision Biosciences’ PBGENE-DMD cleared to enter clinic
Brazilian scientists identify new HDAC6 inhibitors
Financings for Feb. 10, 2026
In the clinic for Feb. 10, 2026
Other news to note for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Pharma company, execs charged with securities fraud
2026 kicks off with $10.8B January financing haul
Iambic raises the bard in AI, pens $1.7B Takeda deal
China amends drug rules to enforce lifecycle accountability
AI meets antibody design: Galux draws $29M series B for drug R&D
Innovent-Lilly $8.5B deal signals new China inflection point
In the clinic for Feb. 10, 2026
Appointments and advancements for Feb. 10, 2026
Financings for Feb. 10, 2026
Regulatory actions for Feb. 10, 2026
Holiday notice
Appointments and advancements for Feb. 9, 2026